Athira Pharma Ownership | Who Owns Athira Pharma?
Athira Pharma Ownership Summary
Athira Pharma is owned by 41.87% institutional investors, 1.95% insiders, and 56.18% retail investors. Perceptive advisors is the largest institutional shareholder, holding 14.10% of ATHA shares. Simplify Propel Opportunities ETF is the top mutual fund, with 3.86% of its assets in Athira Pharma shares.
ATHA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Athira Pharma | 41.87% | 1.95% | 56.18% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Perceptive advisors | 5.40M | 14.10% | $14.32M |
Vanguard group | 1.63M | 4.26% | $4.33M |
Simplify asset management | 1.49M | 3.90% | $3.96M |
Propel bio management | 1.49M | 3.90% | $3.96M |
Tang capital management | 1.05M | 2.75% | $2.79M |
Blackrock | 676.24K | 1.76% | $1.79M |
Dimensional fund advisors lp | 550.35K | 1.44% | $1.46M |
Jacobs levy equity management | 506.81K | 1.32% | $1.34M |
Pathstone | 492.23K | 1.28% | $1.30M |
Two sigma advisers, lp | 360.90K | 0.94% | $956.38K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Propel bio management | 1.49M | 2.57% | $3.96M |
Perceptive advisors | 5.40M | 0.34% | $14.32M |
Tang capital management | 1.05M | 0.28% | $2.79M |
Simplify asset management | 1.49M | 0.27% | $3.96M |
Laird norton trust company | 147.31K | 0.06% | $390.37K |
Integrity financial corp /wa | 32.79K | 0.05% | $86.88K |
Occudo quantitative strategies lp | 40.48K | 0.02% | $107.27K |
Bristlecone advisors | 337.51K | 0.02% | $198.01K |
Bridgeway capital management | 151.07K | 0.01% | $400.34K |
Easterly investment partners | 33.50K | 0.01% | $88.78K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Tang capital management | 1.05M | 0.28% | 200.00K |
Dimensional fund advisors lp | 550.35K | 0.00% | 111.76K |
Royal bank of canada | 55.41K | - | 47.36K |
Invst | 27.00K | 0.01% | 27.00K |
Jacobs levy equity management | 506.81K | 0.01% | 9.34K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Baker bros. advisors lp | - | - | -3.15M |
Wasatch advisors lp | - | - | -1.30M |
Bml capital management | - | - | -900.00K |
Acadian asset management | 318.09K | 0.00% | -231.85K |
Nan fung group | - | - | -180.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Invst | 27.00K | 0.01% | 27.00K | $67.77K |
Sold Out
Holder | Change |
---|---|
Householder group estate & retirement specialist | -150.00 |
Mather group, llc. | -175.00 |
Wells fargo & company/mn | -238.00 |
Macquarie group | -520.00 |
Tower research capital llc (trc) | -4.56K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 59 | -14.49% | 16,127,283 | -27.33% | 41 | 1.25% | 25 | 66.67% | 14 | -39.13% |
Jun 30, 2024 | 69 | -12.66% | 22,193,550 | 2.25% | 57 | 1.79% | 15 | -58.33% | 23 | 27.78% |
Mar 31, 2024 | 79 | 17.91% | 21,705,121 | -0.90% | 56 | 1.72% | 36 | 63.64% | 18 | -10.00% |
Dec 31, 2023 | 67 | -8.22% | 21,901,553 | 2.19% | 57 | 1.81% | 22 | 22.22% | 20 | -33.33% |
Sep 30, 2023 | 73 | -8.75% | 21,432,485 | -2.08% | 56 | 1.69% | 18 | -40.00% | 30 | -11.76% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Simplify Propel Opportunities ETF | 1.49M | 3.86% | - |
Vanguard Total Stock Mkt Idx Inv | 1.07M | 2.77% | - |
Wasatch Micro Cap | 646.90K | 1.68% | 646.90K |
Wasatch Ultra Growth | 544.27K | 1.42% | 544.27K |
Vanguard Institutional Extnd Mkt Idx Tr | 452.02K | 1.17% | - |
Fidelity Extended Market Index | 171.20K | 0.44% | -1.13K |
DFA US Small Cap I | 88.44K | 0.23% | 3.34K |
iShares Micro-Cap ETF | 75.56K | 0.20% | - |
BlackRock Extended Equity Market K | 67.36K | 0.18% | -29.00 |
Bridgeway Ultra-Small Company Market | 67.00K | 0.17% | -62.18K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 02, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | Sell | $6.08K |
Jan 02, 2025 | Litton Mark James | President and CEO | Sell | $14.11K |
Jan 02, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Sell | $4.78K |
Jan 02, 2025 | Renninger Robert | VP of Finance | Sell | $1.62K |
Jan 02, 2025 | Worthington Mark | General Counsel and CCO | Sell | $4.78K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | 5 |
2024 Q2 | 2 | - |
2024 Q1 | - | 5 |
2023 Q4 | 3 | - |
ATHA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools